Haiting An
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Novel potential neuroprotective targets for DengZhanXiXin injection in middle cerebral artery occlusion rats recommended by quantitative proteomics and simulated docking.
Journal: Frontiers in neuroscience
Published: September 20, 2024
Biomolecular Markers of Brain Aging.
Journal: Advances in experimental medicine and biology
Published: July 07, 2023
Neurobiological Mechanisms of Cognitive Decline Correlated with Brain Aging.
Journal: Advances in experimental medicine and biology
Published: July 07, 2023
Scutellarin Modulates the Microbiota-Gut-Brain Axis and Improves Cognitive Impairment in APP/PS1 Mice.
Journal: Journal of Alzheimer's disease : JAD
Published: August 14, 2022
Dengzhanxixin Injection Ameliorates Cognitive Impairment Through a Neuroprotective Mechanism Based on Mitochondrial Preservation in Patients With Acute Ischemic Stroke.
Journal: Frontiers in pharmacology
Published: May 20, 2021
Dengzhan Shengmai capsules and their active component scutellarin prevent cognitive decline in APP/PS1 mice by accelerating Aβ aggregation and reducing oligomers formation.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 16, 2019
Shenqi Yizhi granules protect hippocampus of AD transgenic mice by modulating on multiple pathological processes.
Journal: Journal of ethnopharmacology
Published: August 14, 2019
SQYZ granules, a traditional Chinese herbal, attenuate cognitive deficits in AD transgenic mice by modulating on multiple pathogenesis processes.
Journal: American journal of translational research
Published: February 12, 2018
Gamma rhythm low field magnetic stimulation alleviates neuropathologic changes and rescues memory and cognitive impairments in a mouse model of Alzheimer's disease.
Journal: Alzheimer's & dementia (New York, N. Y.)
Published: November 11, 2017
Deep Brain Magnetic Stimulation Promotes Neurogenesis and Restores Cholinergic Activity in a Transgenic Mouse Model of Alzheimer's Disease.
Journal: Frontiers in neural circuits
Published: January 26, 2017
Triptolide treatment reduces Alzheimer's disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD.
Journal: Disease models & mechanisms
Published: December 07, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026